Skip to main navigation Skip to search Skip to main content

β-arrestin 2 attenuates cardiac dysfunction in polymicrobial sepsis through gp130 and p38

  • Hui Yan
  • , Hui Li
  • , James Denney
  • , Christopher Daniels
  • , Krishna Singh
  • , Balvin Chua
  • , Charles Stuart
  • , Yi Caudle
  • , Ronald Hamdy
  • , Gene LeSage
  • , Deling Yin

Research output: Contribution to journalArticlepeer-review

Abstract

Sepsis is an exaggerated systemic inflammatory response to persistent bacteria infection with high morbidity and mortality rate clinically. β-arrestin 2 modulates cell survival and cell death in different systems. However, the effect of β-arrestin 2 on sepsis-induced cardiac dysfunction is not yet known. Here, we show that β-arrestin 2 overexpression significantly enhances animal survival following cecal ligation and puncture (CLP)-induced sepsis. Importantly, overexpression of β-arrestin 2 in mice prevents CLP-induced cardiac dysfunction. Also, β-arrestin 2 overexpression dramatically attenuates CLP-induced myocardial gp130 and p38 mitogen-activated protein kinase (MAPK) phosphorylation levels following CLP. Therefore, β-arrestin 2 prevents CLP-induced cardiac dysfunction through gp130 and p38. These results suggest that modulation of β-arrestin 2 might provide a novel therapeutic approach to prevent cardiac dysfunction in patients with sepsis.

Original languageEnglish (US)
Pages (from-to)130-137
Number of pages8
JournalBiochemistry and Biophysics Reports
Volume7
DOIs
StatePublished - Sep 1 2016
Externally publishedYes

Keywords

  • Cardiac function
  • Gp130
  • P38
  • Sepsis
  • β-arrestin 2

ASJC Scopus subject areas

  • Biophysics
  • Biochemistry
  • Cell Biology

Fingerprint

Dive into the research topics of 'β-arrestin 2 attenuates cardiac dysfunction in polymicrobial sepsis through gp130 and p38'. Together they form a unique fingerprint.

Cite this